Structure-based optimization of cephalothin-analogue boronic acids as β-lactamase inhibitors
about
Boron chemicals in diagnosis and therapeuticsDesign, Synthesis, Crystal Structures, and Antimicrobial Activity of Sulfonamide Boronic Acids as β-Lactamase InhibitorsStructure of the extended-spectrum β-lactamase TEM-72 inhibited by citrateFragment-guided design of subnanomolar -lactamase inhibitors active in vivoInhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Boron-based inhibitors of acyl protein thioesterases 1 and 2.Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.Fluorescent sensing of fluoride in cellular system.Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.Synthesis of 1,2,3-triazol-1-yl-methaneboronic acids via click chemistry: an easy access to a new potential scaffold for protease inhibitors.Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor DesignTherapeutic potential of boron-containing compounds.Aminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors.From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology.Fragment-based inhibitor discovery against β-lactamaseNew promising β-lactamase inhibitors for clinical use.Synthesis of α-aminoboronic acids.Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase.Covalent docking of selected boron-based serine beta-lactamase inhibitors
P2860
Q27006075-9CDD871C-EB9A-40F0-8A2A-A095B4536095Q27665021-E8558121-03A6-4AE5-9D9B-D34DBF08887AQ27667253-F3CF9152-DDEA-4D7F-B912-A67DA4D8973CQ27674310-3640AE6A-EFAA-40D0-BC91-123FC02DD144Q33606363-43CE6EE9-56EB-44AB-8BA7-0EFEC0E01EBDQ33622976-21A2B2F3-5C0F-4C59-B741-941AAB0FA531Q34317561-7869E397-3DFE-413A-8DDC-6BCC22265985Q34680304-128B7A12-FE22-45B6-8DF9-37F24A3FB130Q34785240-F12851B6-AB58-4003-A253-877B9E297F34Q35014136-3A1EC0AE-1D5A-477F-924C-2A13099B0F77Q35671797-5C714549-626C-40DD-B9E2-3D3F80DC7F11Q35924628-204E8615-22E2-4EB8-A120-886B70CF25D7Q36644892-5F004477-BDC5-4944-970E-51206E25E6F5Q37855884-9D06A80A-BE64-415F-B45D-6E853B526C97Q37856761-E9BA75F4-502B-466D-A879-CA13FE60A93BQ38191916-4B91C6FE-DE82-41B5-8183-DC23A2FE609BQ38196443-7A4C431A-9434-4E1A-B7FD-4C98050DAB5BQ38416383-93A169BF-5633-4F25-800F-033F04D79488Q38725603-74062CDD-B857-442D-8FA4-1A8EBA4EAE4EQ46243175-821F02F9-A00F-48F1-A39D-D14379C54550Q47706910-139FD07E-2727-442F-9147-398342F8675BQ57794478-67389292-FD79-40F1-911F-78CBBC83E777
P2860
Structure-based optimization of cephalothin-analogue boronic acids as β-lactamase inhibitors
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Structure-based optimization o ...... cids as β-lactamase inhibitors
@ast
Structure-based optimization o ...... cids as β-lactamase inhibitors
@en
Structure-based optimization o ...... cids as β-lactamase inhibitors
@nl
type
label
Structure-based optimization o ...... cids as β-lactamase inhibitors
@ast
Structure-based optimization o ...... cids as β-lactamase inhibitors
@en
Structure-based optimization o ...... cids as β-lactamase inhibitors
@nl
prefLabel
Structure-based optimization o ...... cids as β-lactamase inhibitors
@ast
Structure-based optimization o ...... cids as β-lactamase inhibitors
@en
Structure-based optimization o ...... cids as β-lactamase inhibitors
@nl
P2093
P2860
P1476
Structure-based optimization o ...... cids as β-lactamase inhibitors
@en
P2093
Brian K Shoichet
Emilia Caselli
Fabio Prati
Federica Morandi
Stefania Morandi
P2860
P304
P356
10.1016/J.BMC.2007.10.075
P407
P577
2008-02-01T00:00:00Z